首页> 外文期刊>The American Journal of Human Genetics >A Novel Test for Recessive Contributions to Complex Diseases Implicates Bardet-Biedl Syndrome Gene BBS10 in Idiopathic Type 2 Diabetes and Obesity
【24h】

A Novel Test for Recessive Contributions to Complex Diseases Implicates Bardet-Biedl Syndrome Gene BBS10 in Idiopathic Type 2 Diabetes and Obesity

机译:对复杂疾病的隐性贡献的新型测试涉及特发性2型糖尿病和肥胖症的Bardet-Biedl综合征基因BBS10

获取原文
获取原文并翻译 | 示例
           

摘要

Rare-variant association studies in common, complex diseases are customarily conducted under an additive risk model in both single-variant and burden testing. Here, we describe a method to improve detection of rare recessive variants in complex diseases termed RAFT (recessive-allele-frequency-based test). We found that RAFT outperforms existing approaches when the variant influences disease risk in a recessive manner on simulated data. We then applied our method to 1,791 Finnish individuals with type 2 diabetes (T2D) and 2,657 matched control subjects. In BBS10, we discovered a rare variant (c.1189A>G [p.Ile397Val]; rs202042386) that confers risk of T2D in a recessive state (p = 1.38 x 10(-6)) and would be missed by conventional methods. Testing of this variant in an established in vivo zebrafish model confirmed the variant to be pathogenic. Taken together, these data suggest that RAFT can effectively reveal rare recessive contributions to complex diseases overlooked by conventional association tests.
机译:通常,在单变量和负荷测试中,在常见的复杂疾病中的稀有变量关联研究都是在加性风险模型下进行的。在这里,我们描述了一种改善称为RAFT(基于隐性等位基因频率的测试)的复杂疾病中罕见隐性变异的检测方法。我们发现,当变体以隐性方式在模拟数据上影响疾病风险时,RAFT优于现有方法。然后,我们将我们的方法应用于1,791名2型糖尿病(T2D)芬兰人和2,657名匹配的对照受试者。在BBS10中,我们发现了一种罕见的变体(c.1189A> G [p.Ile397Val]; rs202042386),该变体在隐性状态下具有T2D风险(p = 1.38 x 10(-6)),并且会被常规方法忽略。在已建立的体内斑马鱼模型中测试此变体,确认该变体具有致病性。综上所述,这些数据表明,RAFT可以有效揭示对复杂疾病的罕见的隐性贡献,而传统的关联测试却忽略了这一点。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号